Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.92% | 13.81% | 7.63% | 12.53% | 14.07% |
| Total Depreciation and Amortization | -63.41% | 4.76% | -2.22% | -6.52% | -12.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.24% | -18.05% | 110.58% | 21.64% | 150.45% |
| Change in Net Operating Assets | -125.63% | -69.34% | 213.40% | 41.66% | -150.15% |
| Cash from Operations | 28.25% | -32.72% | 25.12% | 23.13% | -11.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 181.68% | -95.69% | 46.97% | 124.31% |
| Cash from Investing | -100.00% | 181.68% | -95.69% | 46.54% | 124.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 469.44% | -- | 131.25% | -- | 50.00% |
| Repurchase of Common Stock | 100.00% | -- | -- | -71.13% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 313.54% | -- | 100.00% | 83.80% | -500.00% |
| Foreign Exchange rate Adjustments | 103.08% | -94.87% | -80.77% | 103.64% | 14.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.82% | 124.62% | -152.13% | 608.63% | 66.45% |